AceLink Therapeutics
Phase 2AceLink consists of a seasoned team of drug development professionals, consultants, and advisors with a rich knowledge of glycolipid biology, rare genetic diseases, and drug development. We collaborate with an extensive network of experienced contract research organizations, academics, and key opinion leaders. This business model allows us to efficiently transform scientific discoveries into impactful new therapies.
About
AceLink consists of a seasoned team of drug development professionals, consultants, and advisors with a rich knowledge of glycolipid biology, rare genetic diseases, and drug development. We collaborate with an extensive network of experienced contract research organizations, academics, and key opinion leaders. This business model allows us to efficiently transform scientific discoveries into impactful new therapies.
Funding History
2Total raised: $106M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile